Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 267-273

  Thomas, Midhun B ^a   Radhakrishnan, Krishna ^a   Gnanadhas, Divya P ^a   Chakravortty, Dipshikha ^a   Raichur, Ashok M ^a,b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Biocompatible; Drug delivery; Electrostatic interaction; Layer by layer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIOPOLYMER; CHITOSAN; DOXORUBICIN; HEPARIN;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MOUSE; NANOFABRICATION; NONHUMAN; PH; ZETA POTENTIAL;

BIOCOMPATIBLE; DRUG DELIVERY; ELECTROSTATIC INTERACTION; LAYER-BY-LAYER;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DOXORUBICIN; HEPARIN; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; MCF-7 CELLS; MICE; MICE, INBRED BALB C; NANOCAPSULES; STATIC ELECTRICITY;

EID: 84872942095     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37737     Document Type: Article

References (26)

1. Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor release from synthetic extracellular matrices. Nature. 2000;408(6815): 998-1000.
2. Yang X, Han X, Zhu Y. (PAH/PSS)5 microcapsules templated on silica core: Encapsulation of anticancer drug DOX and controlled release study. Colloids Surf A Physiochem Eng Asp. 2005;264(2):49-54.
3. Itoh Y, Matsusaki M, Kida T, Akashi M. Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules. Biomacromolecules. 2006;7(10):2715-2718.
4. Kwak NS, Baek Y, Hwang TS. The synthesis of poly(vinylphosphonic acid-co-methacrylic acid) microbeads by suspension polymerization and the characterization of their indium adsorption properties. J Hazard Mater. 2012;203-204(0):213-220.
5. Oh HG, Shin H, Jung H, Lee BH, Choe S. Control of molecular weight of polystyrene using the reverse iodine transfer polymerization (RITP) Emulsion technique. J Colloid Interf Sci. 2011;353(2): 459-466.
6. Sánchez-Navarro M, Rojo J. Synthetic strategies to create dendrimers: Advantages and drawbacks. In: Jesus MdlF, Grazu V, editors. Frontiers of Nanoscience. Amsterdam, The Netherlands: Elsevier; 2012:143-156.
7. Decher G. Fuzzy nanoassemblies: toward layered polymericmulticomposites. Science. 1997;277(5330):1232-1237.
8. Donath E, Sukhorukov GB, Caruso F, Davis SA, Möhwald H. Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes. Angew Chemi Int Ed Engl. 1998;37(16):2201-2205.
9. Sukhorukov GB, Donath E, Lichtenfeld H, et al. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloids Surf A Physicochem Eng Asp. 1998;137(1-3):253-266.
10. Caruso F, Caruso RA, Möhwald H. Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science. 1998;282(5391): 1111-1114.
11. Kwan KC. Oral bioavailability and first-pass effects. Drug Metab Dispos. 1997;25(12):1329-1336.
12. Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170-183.
13. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47(1): 83-97.
14. Kas HS. Chitosan: Properties, preparations and application to microparticulate systems. J Microencapsul. 1997;14(6):689-711.
15. Kawashima Y, Handa T, Kasai A, Takenaka H, Lin SY. The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. Chem Pharm Bull (Tokyo). 1985;33(6):2469-2474.
16. Miyazaki T, Komuro T, Yomota C, Okada S. Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate. J Pharmacol Exp Ther. 1999;290:789-796.
17. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials. 2005;26(18): 3919-3928.
18. Ma L, Gao C, Mao Z, et al. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials. 2003;24(26):4833-4841.
19. Berger J, Reist M, Mayer JM, Felt O, Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur J Pharm Biopharm. 2004;57(1):35-52.
20. Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Söderström G. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. Thromb Res. 1979;15(3-4):531-541.
21. Li Y, Wang HY, Cho CH. Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats. J Pharmacol Exp Ther. 1999;290(2):789-796.
22. Liu W, Sun S, Cao Z, et al. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials. 2005;26(15):2705-2711.
23. Fornari FA, Randolph JK, Yalowich JC, et al. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol. 1994;45(4):649-656.
24. Massart C, Barbet R, Genetet N, Gibassier J. Doxorubicin induces Fas-mediated apoptosis in human thyroid carcinoma cells. Thyroid. 2004;14(4):263-270.
25. Bisht S, Maitra A. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(4):415-425.
26. Levi-Schaffer F, Bernstein A, et al. Reduced toxicity of daunorubicin by conjugation to dextran. Cancer Treat Rep. 1982;66(1):107-114.